LOVF.F Stock Overview

Engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. More details

LOVF.F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	1/6
Financial Health	3/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (11.2x) is below the US market (18.3x)

Risk Analysis

Interest payments are not well covered by earnings

Large one-off items impacting financial results

Profit margins (7.9%) are lower than last year (12.1%)

Does not have a meaningful market cap ($67M)

My Notes

Capture your thoughts, links and company narrative

Cannara Biotech Inc. Competitors

Zhong Yuan Bio-Technology Holdings

OTCPK:ZHYB.F

US$35.4m

AXIL Brands

NYSEAM:AXIL

US$25.0m

United-Guardian

NasdaqGM:UG

US$43.9m

Synergy CHC

NasdaqGM:SNYR

US$38.3m

Price History & Performance

Summary of share price highs, lows and changes for Cannara Biotech
Historical stock prices
Current Share Price	CA$0.54
52 Week High	CA$0.78
52 Week Low	CA$0.39
Beta	1.13
1 Month Change	-8.96%
3 Month Change	19.58%
1 Year Change	-13.58%
3 Year Change	-48.03%
5 Year Change	-48.69%
Change since IPO	-69.88%

Recent updates

Shareholder Returns

	LOVF.F	US Personal Products	US Market
7D	11.9%	-2.5%	-2.8%
1Y	-13.6%	-23.6%	24.1%

Return vs Industry: LOVF.F exceeded the US Personal Products industry which returned -22.6% over the past year.

Return vs Market: LOVF.F underperformed the US Market which returned 24.5% over the past year.

Price Volatility

Is LOVF.F's price volatile compared to industry and market?
LOVF.F volatility
LOVF.F Average Weekly Movement	n/a
Personal Products Industry Average Movement	8.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	18.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine LOVF.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	Zohar Krivorot	cannara.ca

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations.

Cannara Biotech Inc. Fundamentals Summary

How do Cannara Biotech's earnings and revenue compare to its market cap?
LOVF.F fundamental statistics
Market cap	US$46.26m
Earnings (TTM)	US$4.47m
Revenue (TTM)	US$56.76m

11.2x

P/E Ratio

0.9x

P/S Ratio

Is LOVF.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LOVF.F income statement (TTM)
Revenue	CA$81.75m
Cost of Revenue	CA$51.96m
Gross Profit	CA$29.79m
Other Expenses	CA$23.35m
Earnings	CA$6.44m

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.072
Gross Margin	36.44%
Net Profit Margin	7.88%
Debt/Equity Ratio	54.2%

How did LOVF.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 07:38
End of Day Share Price	2025/01/02 00:00
Earnings	2024/08/31
Annual Earnings	2024/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cannara Biotech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution